MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3

FEBS Letters

Volumn 587, Issue 18, 2013, Pages 3069-3075

  Zhang, Yi ^a   Lu, Qiping ^a   Cai, Xun ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Gastric cancer; miR 106a; Multidrug resistance; Runt related transcription factor 3

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MICRORNA; MICRORNA 106A; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; VINCRISTINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; STOMACH CANCER; UPREGULATION;

GASTRIC CANCER; MIR-106A; MULTIDRUG RESISTANCE; RUNT-RELATED TRANSCRIPTION FACTOR 3;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MICRORNAS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84883488449     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.06.058     Document Type: Article

References (29)

1. H. Baba, K. Kuwabara, T. Ishiguro, K. Kumamoto, Y. Kumagai, K. Ishibashi, N. Haga, and H. Ishida Prognostic factors for stage IV gastric cancer Int. Surg. 98 2013 181 187
2. G. Szakacs, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman Targeting multidrug resistance in cancer Nat. Rev. Drug Discov. 5 2006 219 234
3. 4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivo Int. J. Nanomedicine 8 2013 1867 1877
4. S. Kuss, D. Polcari, M. Geissler, D. Brassard, and J. Mauzeroll Assessment of multidrug resistance on cell coculture patterns using scanning electrochemical microscopy Proc. Natl. Acad. Sci. USA 110 2013 9249 9254
5. K. Xu MiR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2 Biochem. J. 446 2012 291 300
6. K. Xu, X. Liang, D. Cui, Y. Wu, W. Shi, and J. Liu MiR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells Mol. Carcinog. 52 2013 70 78
7. C. Baer, R. Claus, and C. Plass Genome-wide epigenetic regulation of miRNAs in cancer Cancer Res. 73 2013 473 477
8. Z. Liang, Y. Li, K. Huang, N. Wagar, and H. Shim Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN Pharm. Res. 28 2011 3091 3100
9. Y. Xu MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest Cancer Lett. 310 2011 160 169
10. T. Catela Ivkovic, G. Aralica, T. Cacev, B. Loncar, and S. Kapitanovic MiR-106a overexpression and pRB downregulation in sporadic colorectal cancer Exp. Mol. Pathol. 94 2013 148 154
11. A.M. Lum, B.B. Wang, L. Li, N. Channa, G. Bartha, and M. Wabl Retroviral activation of the mir-106a microRNA cistron in T lymphoma Retrovirology 4 2007 5
12. Z. Wang MiR-106a Is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS Mol. Carcinog. 52 2013 634 646
13. B. Xiao, J. Guo, Y. Miao, Z. Jiang, R. Huan, Y. Zhang, D. Li, and J. Zhong Detection of miR-106a in gastric carcinoma and its clinical significance Clin. Chim. Acta 400 2009 97 102
14. X. Chen, P. Zheng, Z. Xue, J. Li, W. Wang, F. Xie, Z. Yu, and X. Ouyang CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2 Apoptosis 18 2013 861 869
15. F. Wang MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN Biochem. Biophys. Res. Commun. 434 2013 688 694
16. Y. Wang, X. Gu, Z. Li, J. Xiang, J. Jiang, and Z. Chen MicroRNA expression profiling in multidrug resistance of the 5Fuinduced SGC7901 human gastric cancer cell line Mol. Med. Rep. 7 2013 1506 1510
17. L. Xia MiR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells Int. J. Cancer 123 2008 372 379
18. W. Zhu MiR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP Cancer Chemother. Pharmacol. 69 2012 723 731
19. W. Zhu, D. Zhu, S. Lu, T. Wang, J. Wang, B. Jiang, Y. Shu, and P. Liu MiR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2 Med. Oncol. 29 2012 384 391
20. L. Dylla, and P. Jedlicka Growth-promoting role of the miR-106a approximately 363 cluster in Ewing sarcoma PLoS One 8 2013 e63032
21. Y. Zhao, H. You, F. Liu, H. An, Y. Shi, Q. Yu, and D. Fan Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells Cancer Lett. 185 2002 211 218
22. Y.X. Yang, Z.Q. Xiao, Z.C. Chen, G.Y. Zhang, H. Yi, P.F. Zhang, J.L. Li, and G. Zhu Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR Proteomics 6 2006 2009 2021
23. Y. Zhang Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp Cancer Biol. Ther. 7 2008 540 546
24. N.O. Chimge, and B. Frenkel The RUNX family in breast cancer: relationships with estrogen signaling Oncogene 32 2013 2121 2130
25. K.A. Kang, R. Zhang, G.Y. Kim, S.C. Bae, and J.W. Hyun Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3 Tumour Biol. 33 2012 403 412
26. P.J. Mei, J. Bai, H. Liu, C. Li, Y.P. Wu, Z.Q. Yu, and J.N. Zheng RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration J. Cancer Res. Clin. Oncol. 137 2011 1823 1830
27. T.Y. Kim, H.J. Lee, K.S. Hwang, M. Lee, J.W. Kim, Y.J. Bang, and G.H. Kang Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma Lab. Invest. 84 2004 479 484
28. C. Guo, J. Ding, L. Yao, L. Sun, T. Lin, Y. Song, and D. Fan Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1 Int. J. Cancer 116 2005 155 160
29. S. Horiguchi Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer Mol. Oncol. 7 2013 840 849